2740 Independent review committee assessment of Fagotti carcinomatosis score from 8 laparoscopic images: Ancillary analysis of ANTHALYA, a randomized, open-label, phase II study assessing the efficacy and safety of bevacizumab addition to neoadjuvant therapy for women with ovarian, tubal or peritoneal adenocarcinoma, initially unresectable. (September 2015) - Chéreau, E.; Gouy, S.; Lambaudie, E.; Ballester, M.; Fourchotte, V.; Guyon, F.; Pomel, C.; Colombo, P.E.; Delroeux, D.; Martin-Francoise, S.; Bihan, C.; Leblanc, E.; et al.